Karyopharm Therapeutics
KPTI
#9732
Rank
HK$0.26 B
Marketcap
HK$31.39
Share price
0.00%
Change (1 day)
197.05%
Change (1 year)

P/S ratio for Karyopharm Therapeutics (KPTI)

P/S ratio as of April 2025 (TTM): 0.2329

According to Karyopharm Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.1819. At the end of 2024 the company had a P/S ratio of 0.6091.

P/S ratio history for Karyopharm Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.6091-10.22%
20230.6784-72.32%
20222.455.85%
20212.32-78.04%
202010.5-65.6%
201930.663.1%
201818.8-93.34%
2017282-88.79%
2016> 100032.44%
2015> 1000-64.59%
2014> 1000206.35%
2013> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.12 1,239.01%๐Ÿ‡บ๐Ÿ‡ธ USA
2.25 866.99%๐Ÿ‡บ๐Ÿ‡ธ USA
5.14 2,108.52%๐Ÿ‡บ๐Ÿ‡ธ USA
4.43 1,801.37%๐Ÿ‡บ๐Ÿ‡ธ USA